Plasma lipoprotein (a) concentration and postangioplasty restenosis;LE TAUX PLASMATIQUE DE LIPOPROTEINE (A) PERMET-IL DE PREDIRE LA RESTENOSE APRES ANGIOPLASTIE?

Archives des Maladies du Coeur et des Vaisseaux

Volumn 89, Issue 4, 1996, Pages 425-429

  Bussiere J L ^a   De Bourayne, J ^a   Monsegu J ^a   Corbe H ^b   Berville, J D ^b   Lancelin, B ^c   Ricordel, I ^b   Ollivier, J P ^a  

^a Service de Cardiologie   (France)

^b Service de Biochimie   (France)

^c CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN A;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; RISK ASSESSMENT; BLOOD; COMPARATIVE STUDY; FOLLOW UP; MIDDLE AGED; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RECURRENT DISEASE; REVIEW; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS;

EID: 0029879833     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Desmarais RL, Sarembrock U, Ayers CR et al. Elevated serum lipoprofein (a) as a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation 1995, 91 . 1403-9.
2. Hearn JA, Donohue BC, Ba'albaki H et al. Usefulness of serum lipoprotein(a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1992 ; 69 : 730-9.
3. Rath M, Niendorf A, Reibling T, Dietel M, Krebber HJ, Beisiegel U. Detection and quantification of lipoprotein (a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 1989 ; 9 : 579-92.
4. Loscalzo J. Lipoprotein (a) A unique risk factor for atherothrombotic disease Atherosclerosis 1990 ; 10 : 672-9.
5. Scanu AM. Liproprotein (a). A genetic risk factor for premature coronary heart disease. JAMA 1992 ; 267 : 3326-9.
6. Schreiner PJ, Morrisett JD, Sharrett AR et al. Lipoprotein (a) as a risk factor for preclinical atherosclerosis Arterioscler Thromb 1993 ; 13 : 826-33.
7. Watts GF, Kearney EM, Taub NA, Slavin BM. Lipoprotein (a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolemia J Clin Pathol 1993 ; 46 : 267-70.
8. Hoff HF, Beck GH, Skibinski CI et al. Serum Lp(a) levels as predictor of vein graft stenosis after coronary artery by-pass surgery in patients Circulation 1988 ; 77 : 1238-44.
9. Zenker G, Költringer P, Boné G, Niederkorn K, Pfeiffer K, Jürgens G. Liproprotein (a) as a strong indicator for cerebrovascular disease. Stroke 1986 ; 17 : 942-5.
10. Woo J, Lau E, Lam CWK et al. Hypertension, lipoprotein (a), and apolipoprotein A-I as risk factors for stroke in the Chinese. Stroke 1991 ; 22 : 203-8.
11. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986 ; 59 : 199-204.
12. Donohue B, Lasorda D, Barker D, Barker S et al. Lp(a) correlates restenosis after PTCA (abstract). J Am Coll Cardiol 1993 ; 21 : A 33
13. Mjyata M, Biro S, Arima S et al. High serum level of lipoprotein (a) is a new risk factor in restenosis after percutaneous transluminal angioplasty (abstract). Circulation 1992 ; 86 (suppl I) : 1 54.
14. Michishita I, Shibasaki Y, Umeda K, Mizumo K, Watanabe S, Genda A. Serum lipoprotein (a) as a restenosis risk factor after percutaneous transluminal coronary angioplasty (abstract). Circulation 1991 ; 84 (suppl II) : II 484.
15. Payne M, Jones A, Bartlett W, Murray G, Beattle J. Does serum lipoprotein (a) predict restenosis after coronary angioplasty ? (abstract). Arch Mal Cœur 1993 ; 86 : 168.
16. Cooke T, Sheahan R, Foley D et al. Lipoprotein (a) in restenosis affer percutaneous transluminal coronary angioplasty and coronary artery disease. Circulation 1994 ; 89 :1593-8.
17. Bussière JL, Josse D, Corbé H, Ricordel I, Ollivier JP. Evaluation du risque coronaire : une nouvelle technique de dosage de la lipoprotéine (a). Arch Mal Cœur 1995 ; 88 : 1577-82.
18. Jenner LJ, Ordovas JM, Lamon-FAVA S et al. Effects of age, sex, and menopausal status on plasma lipoprotein (a) levels. The Framingham Offspring Study. Circulation 1993 ; 87 . 1135-41.
19. Utermann G. The mysteries of lipoproiein (a). Science 1989; 246 : 904-10.
20. Cigolini M, Seidell JC, Zenti MG et al. Serum Lp(a) levels in randomized healthy men from different european countries. Eur J Epidemiol 1993 ; 9 : 497-503.
21. Marconiva SM, Albers JJ, Jacobs DR et al. Lipoprotein (a) concentrations and apolipoprotein (a) phenotypes in Caucasians and African Americans. Arterioscler Thromb 1993 ; 13 : 1037-45.
22. Parra HJ, Arveiler D, Evans A et al. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. Arterioscler Thromb 1992 ; 12 : 701-7.
23. Kostner GM. Standardization of Lp(a) assays (letter). Clin Chim Acta 1992; 211 : 191-4.
24. Daida H, Lee YJ, Yokoi H et al. Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Am J Cardiol 1994 ; 73 : 1037-40.